Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales ...

Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales milestones along with tiered single-digit royalties on net product sales - - ...

Accurate interpretation of cancer genomics depends on standardized disease classification, tumor characterization, and ...

Cybersecurity company Arctic Wolf Networks Inc. today announced that it has acquired exposure assessment startup Sevco ...

Tech marketing veteran joins BreachRx to scale the company’s go-to-market strategy and redefine how enterprises run incident ...

Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to ...

Looking for today's NYT Connections hints? Some help and the answers for today's game are right here to help keep your streak alive.

NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Parambil today announced the launch of its agentic AI platform for complex litigation. The release introduces four autonomous agents that actively investigate, ...

A pending court complaint alleges bias after the regulator voted to block radio advertisements about the dangers of sugar. Two months after a public service announcement aired on the SABC radio, South ...

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine Kinases (c-Abl kinases), announces publication of the ...

A pending court complaint alleges bias after the regulator voted to block radio advertisements about the dangers of sugar.